Luis Rodriguez de la Quirda, former Secretary -General; Mar Virginas, President; Elena Kazi, the new Secretary -General of Aseg.
the The Spanish Association of Public Medicines (Aseg), they can accept the Ministry of Health towards its approaches Future drug lawWhich are in the stage of allegations, although the large differences continue in the sections of the project’s capitals. In general, the criticism of the pharmaceutical sector focuses on Article 116, related to The specified price system. Nothing else Take Angel Luis Rodriguez de la Quirda As a general secretary of the employer, Elena Casaus He pointed out that the “adequacy” of the base will form its main working line:We do not agree with the proposed systemIt is not allowed to predict or planning and can cause Supply problemsHe said.
Casaus, who was presented on Thursday “in society” as AESEG Secretary -General, announced his intention to propose a Alternative It focused on the goals of sustainability and Increase in public fees.
He, the head of the employer, has detailed, Elena Fergas, By one “Dynamic” system This would allow price review with a public fee in the market (currently, this 40 percent round). “We believe that the quota system and dynamic prices Better than the chosen pricesIt will be from Monitoring and suppliers cannot be expelledSo the show guarantees will be greater. “
The price of the price in the health system
From Aseg, they contradict this health model, which proposes a patent price system (i.e. once the time for the protection of medicine) would allow “The blind” offers From companies and create cost fork. Both the branch minister, Javier Badilla; As General Manager of Pharmacy, Cesar HernandezThey deny that this procedure will undermine competition. “This is not an auction,” said the first in the last press appearance.
“We want The regime’s sustainable price range Hernandez added and also for companies. It is not a model to keep all products continuously at lower prices, however Without the interventionThe start of the starting cost is requested and that this competition between the producers occurs normally. ”
“Inability to predict” companies and pharmacists
In Fábregas, this idea “does not allow any possibility to predict companies or in terms of values or size.” Add medicines that will also be reduced by the number of suppliers, which “can The deterioration of the show caused” Trademarks, hybrid products… and this generates uncertainty for a huge sector. “
In short, settled, “The influence on the industrial fabric we have in this country, which is one of the largest manufacturers in Europe with 22 production plants“ This will be preferred to the highest prices of countriesSummarize.
However, Fábregas, Casaus and the predecessor, Angel Luis Rodriguez de la Rob, did, Padilla and Hernández Depaleatiator Mood. “I trust that We will continue in this dialogue “We can suggest an alternative system that seems better for us in terms of prediction, presentation and sustainability,” said the new Secretary -General Aseg.
The information published in the medical writing contains data, data and data from official institutions and health professionals. However, given any questions related to your health, consult the opposite health specialist.
